Drug application
PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA (RIBOFLAVIN 5'-PHOSPHATE SODIUM)
Drugs@FDA NDA 203324 · GLAUKOS
Key facts
| Drug name | PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA |
|---|---|
| Active ingredients | RIBOFLAVIN 5'-PHOSPHATE SODIUM |
| Application type | NDA |
| Application number | 203324 |
| Company | GLAUKOS |
| Dosage forms | SOLUTION/DROPS, OPHTHALMIC |
| Strength | EQ 0.146% BASE/ML;EQ 0.146% BASE/ML |
| Marketing status | Prescription |
| Reference listed drug | Yes |
| Latest submission class | Efficacy |
| Latest submission status date | Jul 15, 2016 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- 1–9 Label versions
- 1–9 Products
- None Therapeutic equivalents
- Yes FDA letters on file
- Yes FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: